Fatehy M. Abdel-Haleem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatehy M. Abdel-Haleem has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Faisal K. Algethami
Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90950, Riyadh 11623, Saudi Arabia
1 shared publication Mahmoud S. Rizk
Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt
1 shared publication- Menna El-Beshlawy
Department of Chemistry, Faculty of Women, Ain Shams University, Cairo, Egypt
1 shared publication Menna M. El-Beshlawy
Department of Chemistry, Faculty of Women, Ain Shams University, Cairo, Egypt
1 shared publicationYaser Alhashemi
Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt
1 shared publication- Yomna M. Ahmed
Chemistry Department, Faculty of Science, Cairo University, Giza 12613, Egypt
1 shared publication
Latest Publications
- Open Access
- 7 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (20) , 17959-17971
Pico-molar determination of lurasidone hydrochloride in pharmaceutical formulations using PVC-membrane bulk Miptode
Lurasidone hydrochloride (LRH) is an important medication used for schizophrenia treatment, with minimal side effects of body weight loss, limited sedative capacity and minimal metabolic change; accordingly, its determination is vital, as it is recommended for psychological and memory problems. Molecularly imprinted (MIP) and non-imprinted polymers (NIP) were prepared, and their structures were confirmed by FTIR. MIP and NIP were used as ionophores in bulk membrane optodes (Miptode and Niptode) for LRH determination. Miptode incorporated MIP as an ionophore, tetraphenyl borate as an ion-exchanger, nitrophenyl octyl ether as a plasticizer, and ETH 2439 as a chromoionophore; the response mechanism involved host–guest MIP-LRH complexation via hydrogen bonding, as confirmed by FTIR, followed by deprotonation of the chromoionophore, which caused an absorbance decrease at 675 nm. Compared with Niptode and ion-exchanger-based optodes, Miptode exhibited a very wide concentration range of 10−11 to 10−4 M and a very low detection limit of 10 pM. The superior Miptode selectivity was confirmed by the separate solution and mixed solution methods; the mixed solution method exhibited changes in absorbance (% relative error) of 8, 33, and 29% for Miptode, Niptode, and the ion-exchanger-based optode, respectively. The wide linear concentration range, low detection limit, and high selectivity of Miptode were confirmed by the uniform particle size of the MIP at 47 nm and its homogeneous distribution, as observed by SEM and elemental mapping. Miptode was successfully applied to determine LRH in pure solutions, the pharmaceutical formulation Serodopamoun® tablets, and spiked urine samples, with reasonable accuracy (recovery: 98.5–102.3%) and high precision (relative standard deviation <0.81%). MIP is a suitable alternative for enhancing the ionophore library to prepare sensors for any analyte.
- 7 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (20) , 17959-17971
Open AccessPico-molar determination of lurasidone hydrochloride in pharmaceutical formulations using PVC-membrane bulk Miptode
Lurasidone hydrochloride (LRH) is an important medication used for schizophrenia treatment, with minimal side effects of body weight loss, limited sedative capacity and minimal metabolic change; accordingly, its determination is vital, as it is recommended for psychological and memory problems. Molecularly imprinted (MIP) and non-imprinted polymers (NIP) were prepared, and their structures were confirmed by FTIR. MIP and NIP were used as ionophores in bulk membrane optodes (Miptode and Niptode) for LRH determination. Miptode incorporated MIP as an ionophore, tetraphenyl borate as an ion-exchanger, nitrophenyl octyl ether as a plasticizer, and ETH 2439 as a chromoionophore; the response mechanism involved host–guest MIP-LRH complexation via hydrogen bonding, as confirmed by FTIR, followed by deprotonation of the chromoionophore, which caused an absorbance decrease at 675 nm. Compared with Niptode and ion-exchanger-based optodes, Miptode exhibited a very wide concentration range of 10−11 to 10−4 M and a very low detection limit of 10 pM. The superior Miptode selectivity was confirmed by the separate solution and mixed solution methods; the mixed solution method exhibited changes in absorbance (% relative error) of 8, 33, and 29% for Miptode, Niptode, and the ion-exchanger-based optode, respectively. The wide linear concentration range, low detection limit, and high selectivity of Miptode were confirmed by the uniform particle size of the MIP at 47 nm and its homogeneous distribution, as observed by SEM and elemental mapping. Miptode was successfully applied to determine LRH in pure solutions, the pharmaceutical formulation Serodopamoun® tablets, and spiked urine samples, with reasonable accuracy (recovery: 98.5–102.3%) and high precision (relative standard deviation <0.81%). MIP is a suitable alternative for enhancing the ionophore library to prepare sensors for any analyte.
- Open Access
- 28 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
PVC membrane bulk optode incorporating 4-nitrobenzo-15-crown-5 and sodium tetrakis(1-imidazolyl) borate for the pico-molar determination of silver ion in pharmaceutical formulation
Silver ion (Ag+) is of harmful effects to both environment and human health. Ag+ soluble compounds and salts is used in treating mental illness, epilepsy, nicotine addiction, gastroenteritis, and infectious diseases, including syphilis and gonorrhea, and as anti-infective dermatological agent for controlling nose bleeding. However, high Ag+ doses cause several harmful effects to human health such as irreversible pigmentation of skin and eye, and problems to liver and kidney. A bulk membrane Optode is proposed in this work to measure the Ag+ concentration in the pharmaceutical formulations. The membrane optode is prepared from the ionophore 4-nitobenzo-15-crown-5, the ion-exchanger sodium tetrakis (imidazolyl) borate, the plasticizer o-nitrophenyl octyl ether, and the chromoionophore ETH 5294; these components are dissolved in the PVC/THF slurry to form the membrane. The optode is studied by atomic force microscope and UV–visible spectrophotometer, and its spectrum exhibits two maximum wavelengths of 550 and 665 nm, and response for Ag+ at these maximum wavelengths is reproducible in the concentration range of 10–11 to 10–8 M using acetate buffer of pH 5.0, with very low detection limit of 8.8 × 10–12 M. The most important feature in this work is the selectivity improvement for Ag+ over all interfering ions; the selectivity coefficient logarithm \({logK}_{Ag+, cation}^{opt}\) is found to be − 4.3 for Cu2+, − 5.6 for Ni2+ and − 5.0 for Cd2+. The response mechanism is studied by FTIR, and it depends on ion-exchange of Ag+ and sodium imidazolyl borate, followed by the host–guest complexation between Ag+ and the crown ionophore, which is accompanied by concomitant deprotonation of the chromoionphore. The optode has a response time of 2–3 min within lifetime of 10 days with the same response. The optode can be applied successfully for Ag+ determination in the pharmaceutical formulation, PinkEye Relief® eye drop, which is used for treating inflammation, redness and water discharge of the eye; the high recovery and low standard deviation of the results using calibration curve method confirm the accuracy and precision of the proposed optode for its application in real samples.- 28 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessPVC membrane bulk optode incorporating 4-nitrobenzo-15-crown-5 and sodium tetrakis(1-imidazolyl) borate for the pico-molar determination of silver ion in pharmaceutical formulation
Silver ion (Ag+) is of harmful effects to both environment and human health. Ag+ soluble compounds and salts is used in treating mental illness, epilepsy, nicotine addiction, gastroenteritis, and infectious diseases, including syphilis and gonorrhea, and as anti-infective dermatological agent for controlling nose bleeding. However, high Ag+ doses cause several harmful effects to human health such as irreversible pigmentation of skin and eye, and problems to liver and kidney. A bulk membrane Optode is proposed in this work to measure the Ag+ concentration in the pharmaceutical formulations. The membrane optode is prepared from the ionophore 4-nitobenzo-15-crown-5, the ion-exchanger sodium tetrakis (imidazolyl) borate, the plasticizer o-nitrophenyl octyl ether, and the chromoionophore ETH 5294; these components are dissolved in the PVC/THF slurry to form the membrane. The optode is studied by atomic force microscope and UV–visible spectrophotometer, and its spectrum exhibits two maximum wavelengths of 550 and 665 nm, and response for Ag+ at these maximum wavelengths is reproducible in the concentration range of 10–11 to 10–8 M using acetate buffer of pH 5.0, with very low detection limit of 8.8 × 10–12 M. The most important feature in this work is the selectivity improvement for Ag+ over all interfering ions; the selectivity coefficient logarithm \({logK}_{Ag+, cation}^{opt}\) is found to be − 4.3 for Cu2+, − 5.6 for Ni2+ and − 5.0 for Cd2+. The response mechanism is studied by FTIR, and it depends on ion-exchange of Ag+ and sodium imidazolyl borate, followed by the host–guest complexation between Ag+ and the crown ionophore, which is accompanied by concomitant deprotonation of the chromoionphore. The optode has a response time of 2–3 min within lifetime of 10 days with the same response. The optode can be applied successfully for Ag+ determination in the pharmaceutical formulation, PinkEye Relief® eye drop, which is used for treating inflammation, redness and water discharge of the eye; the high recovery and low standard deviation of the results using calibration curve method confirm the accuracy and precision of the proposed optode for its application in real samples.